Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15119507 | 0.88 | HSD17B10 (0.54) | MAPK1HSD17B10TDP1FYNMAOA | |
| SCHEMBL3921209 | 0.84 | TDP1 (0.57) | MAPK1HSD17B10TDP1 | |
| SCHEMBL24052897 | 0.84 | MAPK1 (0.50) | MAPK1HSD17B10TDP1FYNMAOA | |
| SCHEMBL3922047 | 0.83 | TDP1 (0.55) | MAPK1HSD17B10TDP1 | |
| SCHEMBL13168203 | 0.81 | HSD17B10 (0.50) | MAPK1HSD17B10TDP1FYNMAOA | |
| SCHEMBL15383222 | 0.81 | KDM4E (0.36) | MAPK1HSD17B10 | |
| Isopropyl Alcohol SCHEMBL20235927 | 0.80 | ALDH1A1 (0.38) | MAPK1HSD17B10TDP1LMNATSHR | |
| SCHEMBL16772337 | 0.80 | MAPK1 (0.46) | MAPK1HSD17B10TDP1FYNMAOA | |
| SCHEMBL16097171 | 0.78 | MAPK1 (0.44) | MAPK1HSD17B10TDP1FYNMAOA | |
| SCHEMBL20024457 | 0.78 | HSD17B10 (0.48) | MAPK1HSD17B10TDP1FYNMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365511-A1 | Antiviral Pyrazolopiridinone Compounds | NOVARTIS AG (CH) | 2023-11-16 | — | — | US | disclosed |
| US-20230365511-A1 | Antiviral Pyrazolopiridinone Compounds | NOVARTIS AG (CH) | 2023-11-16 | — | — | US | disclosed |
| US-10144830-B2 | Pretreatment fluids with ammonium metal chelate cross-linker for printing media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2018-12-04 | — | — | US | disclosed |
| US-9670232-B2 | Molecular precursor compounds for zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2017-06-06 | — | — | US | disclosed |
| EP-3102541-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | TRANSTRON SOLUTIONS LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| US-9505024-B2 | Method of producing a printed image on a pre-treated, low-porous or non-porous medium | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2016-11-29 | — | — | US | disclosed |
| US-9455142-B2 | Molecular precursor compounds for ABIGZO zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-09-27 | — | — | US | disclosed |
| US-9404002-B2 | Molecular precursor compounds for indium gallium zinc oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150221771-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150218400-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221506-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20140308447-A1 | PRETREATMENT FLUIDS WITH AMMONIUM METAL CHELATE CROSS-LINKER FOR PRINTING MEDIA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2014-10-16 | — | — | US | disclosed |
| US-8511810-B2 | Inkjet recording method and recording product | SEIKO EPSON CORPORATION (JP) | 2013-08-20 | — | — | US | disclosed |
| WO-2013095332-A1 | PRETREATMENT FLUIDS WITH AMMONIUM METAL CHELATE CROSS-LINKER FOR PRINTING MEDIA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2013-06-27 | — | — | WO | disclosed |
| US-20130156953-A1 | PRETREATMENT FLUIDS WITH ASSOCIATIVE THICKER FOR PRINTING MEDIA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2013-06-20 | — | — | US | disclosed |
| US-20090258203-A1 | Inkjet recording method and recording product | SEIKO EPSON CORPORATION (JP) | 2009-10-15 | — | — | US | disclosed |
| US-20090233065-A1 | INK JET TREATMENT LIQUID, INK JET RECORDING METHOD, AND RECORDED MATTER | SEIKO EPSON CORPORATION | 2009-09-17 | — | — | US | disclosed |
| US-7540909-B2 | Ink composition, ink cartridge, recording method, and recorded product | SEIKO EPSON CORPORATION (JP) | 2009-06-02 | — | — | US | disclosed |
| US-20070263058-A1 | Ink composition, ink cartridge, recording method, and recorded product | SEIKO EPSON CORPORATION. | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218400-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | IKZF3, ZFR, IGSF11 | MAPK1 2958/4885HSD17B10 3285/4885TDP1 3044/4885 |
| US-20150221506-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | AOC3, ZRANB2, AOC2 | MAPK1 2772/4885HSD17B10 1789/4885TDP1 2615/4885 |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | IKZF3, ZRANB2, ZFR | MAPK1 2481/4885HSD17B10 2045/4885TDP1 2024/4885 |
| US-20150221771-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | ZFR, IKZF3, SLC39A11 | MAPK1 3328/4885HSD17B10 2291/4885TDP1 4312/4885 |
| US-20230365511-A1 | Antiviral Pyrazolopiridinone Compounds | ZC3HAV1, ZC3HAV1L, RPL35 | MAPK1 1446/4885HSD17B10 2190/4885TDP1 939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.